40 results about "Microsporum lanosum" patented technology

The invention relates to an application of Scopariusins in the preparation of antihuman fungal medicines, and belongs to the medicinal field. Scopariusins has a very strong Trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans inhibition effect, so the Scopariusins can be used as an antihuman fungal compound, and is expected to be applied in the preparation of related medicines. The skeleton type of the Scopariusins is a brand new skeleton type, and the Scopariusins has a strong human fungus inhibition activity, has prominent substantive characteristics, and is a substantial improvement in the prevention and treatment of human fungal infection.

The invention relates to an application of Lycojaponicumin B in the preparation of medicines for resisting human body fungi, belonging to the field of medicines. The Lycojaponicumin B has very strong inhibitory effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans. Therefore, the Lycojaponicumin B can serve as a compound capable of resisting human body fungi and is expected to be applied in the preparation of related medicines. The application of the Lycojaponicumin B in the preparation of the medicines for resisting human body fungi is disclosed for the first time. As the skeleton type of the Lycojaponicumin B belongs to a brand-new skeleton type, the Lycojaponicumin B has unexpected strong inhibitory activity on human body fungi, and the possibility that other compounds provide revelation does not exist. The Lycojaponicumin B has prominently substantial characteristics and meanwhile has remarkably progressive significance when being used for preventing and treating human body fungi infection.

The invention relates to application of Phyllanthoid A in preparing a medicament for resisting human fungus, and belongs to the field of medicines. Phyllanthoid A has a strong effect in inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, thus can be used as a human fungus resistance compound, is expected to be applied to related medicaments, and is disclosed for the first time. The frame model belongs to a brand-new frame model, and Phyllanthoid A has a strong activity in inhibiting human body fungus, has a highlighted substantial characteristic, and is remarkably progressed in preventing and treating human fungus infection.

The invention relates to an application of Lycojaponicumin B in preparation of a human fungus resisting medicine, belonging to the field of medicines. The Lycojaponicumin B has strong effects of inhibiting trichophyton rubrum, Microsporum lanosum or Trichophyton tonsurans, therefore, the Lycojaponicumin B can be used as a compound with a human fungus resisting function, and is expected to be applied in the preparation of the related medicines. The application of the Lycojaponicumin B in preparation of the human fungus resisting medicine, disclosed by the invention, is disclosed for the first time. The skeleton type of the Lycojaponicumin B belongs to a brand-new skeleton type, and the human fungus inhibiting activity of the Lycojaponicumin B is unexpectedly strong, so that no possibility for providing any inspiration by other compounds exists. The Lycojaponicumin B has outstanding substantial characteristics, meanwhile, has a significant progress in prevention and treatment of human fungal infection.

The invention relates to application of Houttuynoid C in preparing anti-human fungal drugs, belonging to the field of medicine. Houttuynoid C has strong effect of suppressing trichophyton rubrum, microsporum lanosum or trichophyton tonsurans; and therefore, Houttuynoid C can be taken as an anti-human fungal compound and is expected to be applied to preparing related drugs. The use of Houttuynoid C in preparing the anti-human fungal drugs involved in the invention is disclosed for the first time; as the framework type of Houttuynoid C is a brand new framework type and Houttuynoid C has an unexpectedly high inhibition activity for the human fungus without possibility of giving any implication by other compounds, Houttuynoid C has outstanding substantive features; and simultaneously, the application of Houttuynoid C for preventing and treating the human fungus apparently has obvious progress.

The invention relates to applications of Trigonoliimines C in preparation of anti-fungal medicines for human bodies and belongs to the field of medicines. The Trigonoliimines C has strong functions of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore the Trigonoliimines C can be adopted as an anti-fungal compound for human bodies and is expected to be applied in preparation of related medicines.

The invention relates to an application of Houttuynoid A in preparing anti-human fungus drugs and belongs to the field of medicines. The Houttuynoid A is very powerful in effect of inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore, the Houttuynoid A can serve as an anti-human fungus compound, and is expected to be applied in preparing related drugs. The application of the Houttuynoid A in preparing the anti-human fungus drugs is disclosed for the first time. As the skeleton type of the Houttuynoid A is fire-new, and the inhibitory activity of the Houttuynoid A on human fungi is unexpectedly strong, the possibility that any enlightenments are given by other compounds does not exist. The Houttuynoid A is outstanding in substantive feature, and meanwhile, apparently makes a significant progress when being used for preventing and curing human fungus infections.

The invention discloses application of Gypensapogenin A in preparing a medicine for preventing human fungi, belonging to the medicine field. Gypensapogenin a has strong inhibiting functions on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that Gypensapogenin A can be used as a compound for resisting human fungi, and can be applied for preparing relative medicine. The application of Gypensapogenin A in preparing the medicine for preventing human fungi, which is provided by the invention, is disclosed for the first time. The skeleton type belongs to brand-new skeleton type, and the human fungus inhibiting activity of Gypensapogenin A is extremely strong, so that no possibility for providing any prompt by other compounds exists. Gypensapogenin A has outstanding actual characteristics. Meanwhile, Gypensapogenin A has outstanding progress when being used for preventing and treating human fungus infection.

The invention relates to application of Incarviatone A in preparation of an anti-human fungus drug and belongs to the field of medicine. The Incarviatone A has good inhabiting effect on trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, so that the Incarviatone A can serve as an anti-human fungus compound and is hopefully applied in preparation of related drugs. The application of the Incarviatone A in the preparation of the anti-human fungus drug is disclosed for the first time. Due to the fact that the skeleton type is a novel skeleton type and the high human fungus inhibitory activity Incarviatone A is previously unimagined, the possibility that other compounds give any revelation does not exist, and the Incarviatone A has outstanding substantive characteristics and meanwhile has a remarkable improvement in prevention and treatment of human fungus obviously.

The invention relates to an application of polyflavanostilbene A in the preparation of an anti-human fungus medicine, and belongs to the field of medicines. The polyflavanostilbene A has very strong effects on inhibiting trichophyton rubrum, microsporum lanosum or trichophyton tonsurans, and therefore the polyflavanostilbene A can be used as an anti-human fungus compound, and is hopefully to be applied to the preparation of relevant medicines. The invention discloses the application of the polyflavanostilbene A in the preparation of the anti-human fungus medicine for the first time; as the skeleton type is a brand-new skeleton type and the inhibition activity of the polyflavanostilbene A on human fungi is unexpectedly strong, the possibility of being inspired by other compounds is eliminated, and the polyflavanostilbene A has substantive distinguishing features; and the application of the polyflavanostilbene A in the prevention and treatment of human fungus infection is a significant progress.